OR WAIT null SECS
Pharmaceutical Technology
Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.
August 11, 2015
Following a divestiture of certain assets in Europe, the acquisition of Sigma-Aldrich by Merck KGaA will be complete.
The Biosimilars Forum, along with numerous House members, advocated for the use of unique J-codes for biosimilars in a recent letter to CMS.
August 07, 2015
European Union regulators said Pfizer must divest its infliximab biosimilar candidate and some sterile injectables for the merger with Hospira to be completely approved.
July 30, 2015
The Generic Pharmaceutical Association and the Biosimilars Council wrote an open letter to President Barack Obama protesting the patent protections outlined in the Trans-Pacific Partnership.
July 27, 2015
The deal to acquire Allergan’s generic-drug business is valued at $40.5 billion.
FDA approved the drug for a more narrow indication in the US than did EMA for Repatha, Praluent’s fiercest competitor.